{"data":[{"accessionNo":"0001897612-26-000462","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0000874015","issuerName":"IONIS PHARMACEUTICALS INC","ticker":"IONS","cusip":"462222100","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6159027,"percentOfClass":3.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0001422849-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000874015","issuerName":"Ionis Pharmaceuticals, Inc.","ticker":"IONS","cusip":"462222100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Capital World Investors","reportingCik":null,"personType":"IA","sharesOwned":21186369,"percentOfClass":12.8,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0002100119-26-000716","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000874015","issuerName":"Ionis Pharmaceuticals Inc","ticker":"IONS","cusip":"462222100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":8344732,"percentOfClass":5.05,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0000102909-26-001551","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0000874015","issuerName":"Ionis Pharmaceuticals Inc","ticker":"IONS","cusip":"462222100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0001897612-26-000248","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000874015","issuerName":"IONIS PHARMACEUTICALS INC","ticker":"IONS","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":9108019,"percentOfClass":5.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0001422849-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000874015","issuerName":"Ionis Pharmaceuticals, Inc.","ticker":"IONS","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Capital World Investors","reportingCik":null,"personType":"IA","sharesOwned":17961299,"percentOfClass":11.1,"filedAt":"2026-01-07","canonicalUrl":"https://xoomar.com/markets/stocks/ions"},{"accessionNo":"0001897612-25-000512","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000874015","issuerName":"IONIS PHARMACEUTICALS INC","ticker":"IONS","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":13157114,"percentOfClass":8.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ions"}],"updatedAt":"2026-10-29T04:33:59.633Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ions","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}